Legend Biotech

(NASDAQ) LEGN

Current Price$29.46

Market Cap$5.46B

Since IPO (2020)-21%

5 Year-26%

1 Year+1%

1 Month+13%

Legend Biotech Financials at a Glance

Market Cap

$5.46B

Revenue (TTM)

$1.14B

Net Income (TTM)

$250.18M

EPS (TTM)

$-1.36

P/E Ratio

-21.59

Dividend

$0.00

Beta (Volatility)

0.75 (Low)

Dividend

$0.00

Beta (Volatility)

0.75 (Low)

Price

$29.46

Volume

2,049,729.488

Open

$27.50

Price

$29.46

Volume

2,049,729.488

Open

$27.50

Previous Close

$29.37

Daily Range

$27.19 - $30.10

52-Week Range

$16.24 - $45.30

Dividend

$0.00

Beta (Volatility)

0.75 (Low)

Price

$29.46

Volume

2,049,729.488

Open

$27.50

Previous Close

$29.37

Daily Range

$27.19 - $30.10

52-Week Range

$16.24 - $45.30

LEGN News

Page 1

LEGN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Legend Biotech

Industry

Biotechnology

Sector

Health Care

Employees

2,900

CEO

Ying Huang, PhD

Website

www.legendbiotech.com

Headquarters

Somerset, NJ 08873, US

LEGN Financials

Key Financial Metrics (TTM)

Gross Margin

55%

Operating Margin

-12%

Net Income Margin

-22%

Return on Equity

-25%

Return on Capital

-12%

Return on Assets

-16%

Earnings Yield

-4.63%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.46B

Shares Outstanding

185.74M

Volume

2.05M

Avg. Volume

2.10M

Financials (TTM)

Gross Profit

$620.80M

Operating Income

$136.50M

EBITDA

$232.30M

Operating Cash Flow

$100.47M

Capital Expenditure

$67.58M

Free Cash Flow

$168.04M

Cash & ST Invst.

$948.60M

Total Debt

$413.70M

Legend Biotech Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$305.10M

+56.4%

Gross Profit

$129.20M

+4.4%

Gross Margin

42.35%

N/A

Market Cap

$5.46B

N/A

Market Cap/Employee

$2.10M

N/A

Employees

2,600

N/A

Net Income

$54.30M

+46.2%

EBITDA

$32.00M

+64.0%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$445.31M

-30.7%

Accounts Receivable

$186.61M

+11.8%

Inventory

$37.10M

+19.9%

Long Term Debt

$112.10M

-68.6%

Short Term Debt

$277.20M

+5090.0%

Return on Assets

-15.67%

N/A

Return on Invested Capital

-12.48%

N/A

Free Cash Flow

$111.33M

-5.3%

Operating Cash Flow

$85.35M

+17.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CGONCG Oncology, Inc. Common stock

CGONCG Oncology, Inc. Common stock$64.25-0.53%

SRRKScholar Rock Holding Corporation

SRRKScholar Rock Holding Corporation$48.13+0.86%

XENEXenon Pharmaceuticals Inc.

XENEXenon Pharmaceuticals Inc.$54.17+0.09%

CELCCelcuity Inc.

CELCCelcuity Inc.$138.23-3.02%

TARSTarsus Pharmaceuticals, Inc.

TARSTarsus Pharmaceuticals, Inc.$62.26-1.92%

IDYAIDEAYA Biosciences, Inc.

IDYAIDEAYA Biosciences, Inc.$29.10-1.49%

IRONDisc Medicine, Inc.

IRONDisc Medicine, Inc.$66.82-0.46%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

FFord Motor Company

FFord Motor Company$14.93+0.09%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.85+0.02%

INTCIntel

INTCIntel$119.84+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.26+0.04%

INFQInfleqtion

INFQInfleqtion $16.35+0.11%

TET1 Energy Inc.

TET1 Energy Inc.$8.08-0.07%

FUTUFutu

FUTUFutu$89.76-0.28%

Questions About LEGN

What is the current price of Legend Biotech?

Legend Biotech is trading at $29.37 per share.

What is the 52-week range for Legend Biotech?

Over the past 52 weeks, Legend Biotech has traded between $16.24 and $45.30.

How much debt does Legend Biotech have?

As of the most recent reporting period, Legend Biotech reported total debt of $389.31M.

How much cash does Legend Biotech have on hand?

Legend Biotech reported $646.42M in cash and cash equivalents in its most recent financial results.

What is Legend Biotech’s dividend yield?

Legend Biotech does not currently have a dividend yield.

Legend Biotech

Legend Biotech Financials at a Glance

LEGN News

A China Tech Fund Opens a Biotech Position — Here's What That Actually Signals

Why Legend Biotech Stock Crushed the Market on Monday

What Companies Does Johnson & Johnson Own?

After Jumping 49% in 1 Month, Is It Too Late to Buy Legend Biotech?

Why Shares of Legend Biotech Jumped Wednesday

Why Legend Biotech's Shares Jumped 14.2% On Tuesday

Why Legend Biotech's Shares Jumped 11.8% on Wednesday

2 Biotechs With Recent FDA Approvals to Hold for the Next Decade

LEGN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Legend Biotech

LEGN Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Legend Biotech Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About LEGN

What is the current price of Legend Biotech?

What is the 52-week range for Legend Biotech?

How much debt does Legend Biotech have?

How much cash does Legend Biotech have on hand?

What is Legend Biotech’s dividend yield?

Premium Investing Services